BioCentury
ARTICLE | Emerging Company Profile

Cellectricon: Insights from inside

February 7, 2005 8:00 AM UTC

In many indications it is difficult to perform cell-based assays quickly and reproducibly. As a result, companies often have to rely on data derived from in vitro interactions. Cellectricon AB is developing chip-based consumables to perform high throughput cell-based assays that produce high-quality data.

One area where Cellectricon believes its high throughput assays will provide a benefit is ion channel screening...